RnRmarketResearch.

com adds report CountryFocus: Healthcare, Regulatory and Reimbursement

Landscape France to its store.

The industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape France. The report is an essential source of information and an analysis on
the healthcare, regulatory and reimbursement landscape of France. The report identifies the key trends
in the healthcare market and provides insights on the demographic, regulatory, reimbursement
landscape and healthcare infrastructure of France. Most importantly, the report provides valuable
insights on the trends and segmentation of the pharmaceutical and medical devices market. This report
is built using data and information sourced from proprietary databases, secondary research and inhouse analysis by GlobalDatas team of industry experts.

In 2012, frances population was approximately 65.3 million. The growth rate of the French population is
decreasing steadily and this may be due to a negative balance between the mortality and birth rates,
and low net rate of immigration. French policymakers are now presented with the problems of a
Eurozone crisis, a declining population of the working age group and an increasing elderly population.
The pharmaceutical market in France was estimated at $45.3 billion in 2012 and is expected to reach
approximately $51 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 1.5%. The
medical devices market size was approximately $14.7 billion in 2012 and is expected to reach
approximately $20.8 billion by 2020 with a projected CAGR of 4.5%.

Complete report available @ http://www.rnrmarketresearch.com/countryfocus-healthcare-regulatoryand-reimbursement-landscape-france-market-report.html .

The positive trends in the French healthcare market can be attributed primarily to:

Scope

Increasing elderly population

Universal healthcare insurance
High degree of access to healthcare facilities

Overview of the pharmaceutical and medical devices market of France including the market size,
market segmentation, key drivers and barriers.
Profile and SWOT analysis of the major players in the pharmaceutical and medical devices
market. The key players covered for the pharmaceutical market are Sanofi, Novartis,
F.Hoffmannla Roche, GlaxoSmithKline, and AstraZeneca. The key players covered for the
medical devices market are Siemens Healthcare, Hoffmann-La Roche, Medtronic, Essilor
Internaltional and GlaxoSmithKline.
Insightful review on the reimbursement and regulatory landscape. Analysis includes details of
the healthcare reimbursement process, the regulatory agencies and the approval processes for
new drugs and medical devices.
A detailed analysis of the political and economic environment of France including the economic
indicators, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities and challenges for growth that exist in the healthcare market
of France.

Reasons to Buy

Develop business strategies by understanding the trends shaping and driving the healthcare
market of France.
Drive revenue by understanding the key trends, and reimbursement and regulatory policies,
pharmaceutical and medical devices market segments and companies likely to impact the
French healthcare market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape
and by analyzing the performance of the various competitors.
Organize your sales and marketing efforts by identifying the market categories and segments
that present the maximum opportunities for consolidations, investments and strategic
partnerships.
Identify, understand and capitalize on the opportunities and challenges in the healthcare market
of France.

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=97015 .

(This is a premium report priced at US$1995 for a single user PDF.)

List of Tables

Table 1: Pharmaceutical Market, France, Revenue ($bn), 20072012

Table 2: Pharmaceutical Market, France, Revenue ($bn), Forecast, 20132020

Table 3: Pharmaceutical Market, France, Imports and Exports ($bn), 20072012
Table 4: Price Margins of Pharmaceutical Distribution Channel (%), France, 2011
Table 5: Generic Pharmaceutical Market Share (%), France, 20072012
Table 6: Major Generic Products, Volume (Boxes million), France, 2011
Table 7: Major Generic Products, Revenue ($m), France, 2011
Table 8: Drugs Going Off Patent, Revenue ($m), Global, 20112015
Table 9: OTC Pharmaceutical Market, France, Revenue ($bn), 20082012
Table 10: Major OTC Drug Classes, France, Revenue ($m), 2011
Table 11: Major Therapeutic Areas, France, Revenue Share (%), 2011
Table 12: Major Products, Sanofi, Global, Revenue ($m), 2012
Table 13: Late-Stage Pipeline, Sanofi, 2013
Table 14: Major Products, Novartis, Global, Revenue ($m), 2012
Table 15: Planned Filings, Novartis, 2012 to = 2016
Table 16: Major Products, Roche, Global, Revenue ($m), 2012
Table 17: Late Stage Pipeline, Roche, 2012
Table 18: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2011
Table 19: Late-Stage Pipeline, GlaxoSmithKline, 2012
Table 20: Major Products, AstraZeneca, Global, Revenue ($m), 2011
Table 21: Late-Stage Pipeline, AstraZeneca, 2012
Table 22: Medical Device Market, France, Revenue ($bn), 20072012
Table 23: Medical Device Market, France, Revenue Forecast ($bn), 20132020
Table 24: Medical Device Market, France, Segment Revenue ($bn), 2012
Table 25: In Vitro Diagnostics Market, France, Revenue ($m), 20072012

Table 26: In Vitro Diagnostics Market, France, Sales Trend for Major Players* ($m), 2011
Table 27: Ophthalmic Device Market, France, Revenue ($m), 20072012
Table 28: Ophthalmic Device Market, France, Sales Trend for Major Players* ($m), 2011
Table 29: Cardiovascular Device Market, France, Revenue ($m), 20072012
Table 30: Cardiovascular Device Market, France, Sales Trend for Major Players ($m)*, 2011
Table 31: Orthopedic Device Market, France, Revenue ($m), 20072012
Table 32: Orthopedic Device Market, France, Sales Trend for Major Players ($m)*, 2011
Table 33: Hospital Supplies Market, France, Revenue ($m), 20072012
Table 34: Hospital Supplies, France, Sales Trend for Major Players ($m)*, 2011
Table 35: Diagnostics Market, France, Revenue ($bn), 20072012
Table 36: Diagnostic Market, France, Revenue ($bn), Forecast, 20132020
Table 37: Major Medical Device Companies, France, Revenue ($m), 2011
Table 38: Major Products, Siemens, Global, Revenue ($m), 2012
Table 39: Major Products, Roche, Revenues ($m), 2012
Table 40: Major Products, Medtronic, Global, Revenue ($m), 2012
Table 41: Major Segments, Essilor International, Global, Revenue ($m), 2011
Table 42: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2011
Table 43: Drug Reimbursement Categories and Rates, France, 2011
Table 44: Source of Public Health Insurance Fund, France, Share (%), 2011
Table 45: Healthcare Spending, France, Patient's Share (%), 20072012
Table 46: Healthcare Consumer Price Index, France, Annual Change (%), 20072012
Table 47: Patent Application Fees ($), France, 2013
Table 48: Trademark Registration Fees ($), France, 2013
Table 49: Pharmacist Requirement by Revenue of Pharmacy, France, 2013

Table 50: GDP per Capita ($), France, 20072012

Table 51: GDP per Capita ($), France, Forecast, 20132020
Table 52: GDP, France, Annual Growth (%), 20072012
Table 53: GDP, France, Annual Growth (%), Forecast, 20132020
Table 54: GNI per Capita ($), France, 20072012
Table 55: Average Consumer Price Index, France, 20072012
Table 56: Average Consumer Price Index, France, Forecast, 20132020
Table 57: Average Consumer Price, France, Annual Change (%), 20072012
Table 58: Average Consumer Price, France, Annual Change (%), Forecast, 20132020
Table 59: Currency Exchange Rate (/$), France, 20072012
Table 60: Foreign Direct Investment ($bn), France, 20072012
Table 61: Foreign Exchange Reserves ($bn), France, 20072012
Table 62: Imports of Goods and Services ($bn), France, 20072012
Table 63: Exports of Goods and Services ($bn), France, 20072012
Table 64: General Government Structural Balance ($bn), France, 20072012
Table 65: General Government Net Debt ($bn), France, 20072012
Table 66: Major Industries, France, Gross Value Added ($bn), 2011
Table 67: Population (m), France, 20072012
Table 68: Population (m), France, Forecast, 20132020
Table 69: Urban and Rural Population, France, Share (%), 20072012
Table 70: Urban and Rural Population, France, Share (%), Forecast, 20132020
Table 71: Age Groups, France, Population Distribution (%), 20072012
Table 72: Age Groups, France, Population Distribution (%), Forecast, 20132020
Table 73: Births (per 1,000 Population), France, 20072012

Table 74: Mortality (per 1,000 Population), France, 20072012

Table 75: Main Causes of Mortality (%), France, 2008
Table 76: Children <5 Years Age, France, Mortality Rate (per 1,000 Live Births), 20072012
Table 77: Immunization Rate (%), France, 20072012
Table 78: Main Causes of Male Mortality (`000), France, 2008
Table 79: Main Causes of Female Mortality (`000), France, 2008
Table 80: Gender Ratio (M/F), France, 20072012
Table 81: Life Expectancy at Birth (Years), France, 20072012
Table 82: Levels of Education, France, Students Enrollment (million), 2010
Table 83: Higher Education, France, Students Enrollment (000), 2010
Table 84: Unemployment (%), France, 20072012
Table 85: Hospital In-patients (per 1,000 Population), France, 2010
Table 86: Major Diseases, France, DALYs (per 100,000 Population), 2009
Table 87: Public and Private Hospitals Establishments, France, 20072012
Table 88: Public and Private Hospitals Beds (000), France, 20072012
Table 89: Diagnostic Canters, France, 20072012
Table 90: Diagnostic Units (per 1,000,000 Population), France, 20072012
Table 91: Hospital Beds (per 1,000 Population), France, 20072012
Table 92: Physicians (per 1,000 Population), France, 20072012
Table 93: CO2 Emissions (Million Tons), France, 20072012
Table 94: PM-10 Emissions (gms/m3), France, 20072012
Table 95: Nitrates and Orthophosphates Content, 20072012
Table 96: Solid Waste (Million Tons), France, 20072012
Table 97: Nature of Collected Waste, France, Share (%), 2010

Table 98: Waste Handling, France, Share (%), 2010

Table 99: Nurses (per 1,000 Population), France, 20072012
Table 100: Pharmacists (per 1,000 Population), France, 20072012
Table 101: Dentists (per 1,000 Population), France, 20072012
Table 102: Healthcare Expenditures (% of GDP), France, 20072012
Table 103: Healthcare Expenditure, France, Share of Major Components (%), 2011
Table 104: Healthcare Expenditures, France, Public-Private Share (%), 20072012
Table 105: Pharmaceutical and Medical R&D Expenditures ($bn), France, 20072012
Table 106: Public and Private R&D Expenditure, France, Share (%), 2011
Table 107: Major Healthcare Trade Fairs, France, 20132014

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=97015

.

About Us:
RnRmarketResearch.com is your single source for all market research needs. Our database includes
450,000+ market research reports from over 95 leading global publishers & in-depth market research
studies of over 5000 micro markets. We offer you customization options on reports by & custom reports
through MarketsandMarkets.com. With comprehensive information about the publishers and the
industries for which they publish market research reports, we help you in your purchase decision by
mapping your information needs with our huge collection of reports.